According to the Food and Drug Administration (FDA), three doses of the Pfizer-BioNTech coronavirus vaccine appeared to be effective in preventing Covid illness in children under five, judging by the level of virus-blocking antibodies the shots induced, reports the NY Times.
Some public health professionals anticipate that the FDA will approve Moderna’s and Pfizer’s vaccinations, giving parents a choice.
After the FDA acts, the Centers for Disease Control and Prevention (CDC) must also weigh in with its recommendations. The only Americans who are not yet eligible for vaccinations are the roughly 18 million children under five. — The Health
